Inventor · disambiguated record
Masayoshi Uehata
Also filed as: UEHATA MASAYOSHI
11 granted patents·1 pending application·435 citations·filing 1992–2006
93Inventor score
Top patents by PatentIndex Score
12 records- 0194US6218410B1Medicines comprising Rho kinase inhibitorYOSHITOMI PHARMACEUTICAL·Filed 1997·Granted Apr 17, 2001·163 cites·18 claims
- 0291US5478838A4-amino(alkyl)cyclohexane-1-carboxamide compound and use thereofYOSHITOMI PHARMACEUTICAL·Filed 1992·Granted Dec 26, 1995·74 cites·10 claims
- 0390US6451825B1Pharmaceutical agent containing Rho kinase inhibitorMITSUBISHI PHARMA CORP·Filed 2001·Granted Sep 17, 2002·44 cites·2 claims
- 0488US6906061B2Pharmaceutical agent containing Rho kinase inhibitorMITSUBISHI PHARMA CORP·Filed 2002·Granted Jun 14, 2005·30 cites·10 claims
- 0587US6649625B2Agent for prophylaxis and treatment of glaucomaSENJU PHARMA CO·Filed 2002·Granted Nov 18, 2003·27 cites·9 claims
- 0680US6844354B1Agent for prophylaxis and treatment of interstitial pneumonia and pulmonary fibrosisMITSUBISHI PHARMA CORP·Filed 2000·Granted Jan 18, 2005·18 cites·8 claims
- 0778US7109208B2Visual function disorder improving agentsMITSUBISHI PHARMA CORP·Filed 2002·Granted Sep 19, 2006·13 cites·8 claims
- 0878US6673812B1Preventives/remedies for glaucomaSENJU PHARMA CO·Filed 1999·Granted Jan 6, 2004·42 cites·9 claims
- 0975US7696194B2Visual function disorder improving agentsSENJU PHARMA CO·Filed 2006·Granted Apr 13, 2010·2 cites·2 claims
- 1075US6794398B1Preventive/remedies for liver diseasesMITSUBISHI PHARMA CORP·Filed 2000·Granted Sep 21, 2004·15 cites·9 claims
- 1165US6933305B2Amide compounds and use thereofMITSUBISHI PHARMA CORP·Filed 2001·Granted Aug 23, 2005·7 cites·7 claims
- 1244US2006122214A1Agent for prophylaxis and treatment of angiostenosisKAI HISASHI·Filed 2005·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Masayoshi Uehata files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →